{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:36:16Z","timestamp":1740105376772,"version":"3.37.3"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19390286"],"award-info":[{"award-number":["JP19390286"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bbrc.2024.150894","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T01:29:11Z","timestamp":1729733351000},"page":"150894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Triple-regulated conditionally replicating adenovirus for effective and safer treatment of peritoneal carcinomatosis"],"prefix":"10.1016","volume":"737","author":[{"given":"Junichi","family":"Kamizono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Nishikawaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2015-1730","authenticated-orcid":false,"given":"Satoshi","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minako","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Kamisasanuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0534-9845","authenticated-orcid":false,"given":"Kaoru","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2327-0486","authenticated-orcid":false,"given":"Ken-ichiro","family":"Kosai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.150894_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2024.150894_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41467-020-20429-0","article-title":"Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram","volume":"12","author":"Chen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150894_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2024.150894_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1245\/s10434-019-07624-0","article-title":"Gastric cancer peritoneal carcinomatosis risk score","volume":"27","author":"Ji","year":"2020","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.bbrc.2024.150894_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/77283","article-title":"Replicative adenoviruses for cancer therapy","volume":"18","author":"Alemany","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2024.150894_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/v13122502","article-title":"Adenovirus biology, recombinant adenovirus, and adenovirus usage in gene therapy","volume":"13","author":"Watanabe","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.bbrc.2024.150894_bib7","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/sj.gt.3302540","article-title":"An efficient construction of conditionally replicating adenoviruses that target tumor cells with multiple factors","volume":"12","author":"Nagano","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbrc.2024.150894_bib8","first-page":"3143","article-title":"The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression","volume":"59","author":"Li","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2024.150894_bib9","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1158\/0008-5472.CAN-04-2657","article-title":"Survivin-responsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication","volume":"65","author":"Kamizono","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2024.150894_bib10","first-page":"681","article-title":"Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: a promising implication of telomerase-dependent targeted cancer gene therapy","volume":"29","author":"Murofushi","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2024.150894_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/cgt.2011.44","article-title":"Assessment of an altered E1B promoter on the specificity and potency of triple-regulated conditionally replicating adenoviruses: implications for the generation of ideal m-CRAs","author":"Horikawa","year":"2011","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbrc.2024.150894_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1479-5876-12-27","article-title":"Survivin-responsive conditionally replicating adenovirus kills rhabdomyosarcoma stem cells more efficiently than their progeny","volume":"12","author":"Tanoue","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbrc.2024.150894_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2015.26","article-title":"Conditionally replicating adenovirus prevents pluripotent stem cell-derived teratoma by specifically eliminating undifferentiated cells","volume":"2","author":"Mitsui","year":"2015","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.bbrc.2024.150894_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.omtm.2017.03.002","article-title":"Viral vector-based innovative approaches to directly abolishing tumorigenic pluripotent stem cells for safer regenerative medicine","volume":"5","author":"Mitsui","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.bbrc.2024.150894_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.trsl.2024.07.002","article-title":"An optimal promoter regulating cytokine transgene expression is crucial for safe and effective oncolytic virus immunotherapy","volume":"273","author":"Kawakami","year":"2024","journal-title":"Transl. Res."},{"key":"10.1016\/j.bbrc.2024.150894_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/jhep.2003.50018","article-title":"An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in mice","volume":"37","author":"Terazaki","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2024.150894_bib17","first-page":"3758","article-title":"Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival","volume":"56","author":"Chen","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2024.150894_bib18","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1073\/pnas.92.7.2577","article-title":"Combination gene therapy for liver metastasis of colon carcinoma in vivo","volume":"92","author":"Chen","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2024.150894_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbrc.2021.01.009","article-title":"Optimization of adenoviral gene transfer in human pluripotent stem cells","volume":"541","author":"Mitsui","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2024.150894_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.119014","article-title":"Safe and low-dose but therapeutically effective adenovirus-mediated hepatocyte growth factor gene therapy for type 1 diabetes in mice","volume":"268","author":"Matsuda","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2024.150894_bib21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00595-003-2617-0","article-title":"Evaluation of carcinoembryonic antigen mRNA in living, necrotic, and apoptotic gastric cancer cells by reverse transcriptase-polymerase chain reaction","volume":"33","author":"Kojima","year":"2003","journal-title":"Surg. Today"},{"key":"10.1016\/j.bbrc.2024.150894_bib22","first-page":"77","article-title":"Adenoviral gene transduction of hepatocyte growth factor elicits inhibitory effects for hepatoma","volume":"27","author":"Yuge","year":"2005","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2024.150894_bib23","first-page":"549","article-title":"Gene therapy eradicating distant disseminated micro-metastases by optimal cytokine expression in the primary lesion only: novel concepts for successful cytokine gene therapy","volume":"24","author":"Nagano","year":"2004","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2024.150894_bib24","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/S0003-4975(02)03572-5","article-title":"Adenoviral herpes simplex virus thymidine kinase gene therapy in an orthotopic lung cancer model","volume":"73","author":"Fukunaga","year":"2002","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.bbrc.2024.150894_bib25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41417-023-00720-0","article-title":"BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors","volume":"31","author":"Conley","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbrc.2024.150894_bib26","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.1007\/s00432-023-04735-w","article-title":"Oncolytic adenoviruses and the treatment of pancreatic cancer: a review of clinical trials","volume":"149","author":"Taylor","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2024.150894_bib27","first-page":"98","article-title":"Bases and foundations of the treatment of peritoneal carcinomatosis: review article","volume":"18","author":"Castro-Mesta","year":"2016","journal-title":"Med. Univ."},{"key":"10.1016\/j.bbrc.2024.150894_bib28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fonc.2020.00475","article-title":"Delivery and biosafety of oncolytic virotherapy","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2024.150894_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/scbi.1998.0119","article-title":"The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues","volume":"9","author":"Hammarstrom","year":"1999","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2024.150894_bib30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1006\/bbrc.1996.1738","article-title":"P21waf-1\/cip-1\/sdi-1 is expressed at G1 phase in primary culture of hepatocytes from old rats, presumably preventing the cells from entering the S phase of the cell cycle","volume":"228","author":"Sawada","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2024.150894_bib31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1006\/bbrc.1998.8293","article-title":"Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor","volume":"244","author":"Kosai","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2024.150894_bib32","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1089\/hum.1998.9.9-1293","article-title":"Retrovirus-mediated in vivo gene transfer in the replicating liver using recombinant hepatocyte growth factor without liver injury or partial hepatectomy","volume":"9","author":"Kosai","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbrc.2024.150894_bib33","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1099\/0022-1317-81-11-2605","article-title":"Blood clearance rates of adenovirus type 5 in mice","volume":"81","author":"Alemany","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbrc.2024.150894_bib34","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/aps.2016.59","article-title":"Dendritic cells serve as a \"Trojan horse\" for oncolytic adenovirus delivery in the treatment of mouse prostate cancer","volume":"37","author":"Li","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbrc.2024.150894_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1099\/0022-1317-40-1-45","article-title":"Infection of mouse liver by human adenovirus type 5","volume":"40","author":"Duncan","year":"1978","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbrc.2024.150894_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.omto.2019.05.001","article-title":"An oncolytic adenovirus vector expressing p14 FAST protein induces widespread syncytium formation and reduces tumor growth rate in vivo","volume":"14","author":"Del Papa","year":"2019","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.bbrc.2024.150894_bib37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF01487691","article-title":"A new hamster model for adenoviral vaccination","volume":"100","author":"Hjorth","year":"1988","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bbrc.2024.150894_bib38","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-05-3497","article-title":"Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors","volume":"66","author":"Thomas","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2024.150894_bib39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12967-016-0895-8","article-title":"Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters","volume":"14","author":"Kim","year":"2016","journal-title":"J. Transl. Med."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2401430X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2401430X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T21:09:47Z","timestamp":1739221787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2401430X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":39,"alternative-id":["S0006291X2401430X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150894","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triple-regulated conditionally replicating adenovirus for effective and safer treatment of peritoneal carcinomatosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"150894"}}